Pan-European distribution agreement for broad-spectrum and isolate CBD, 28 January 2020

A new agreement has been reached for the distribution of CBD isolate and broad-spectrum CBD.

PharmaCielo, the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings, recently announced it has signed a three-year pan-European distribution agreement.

In the agreement the company’s high-grade CBD isolate and broad-spectrum CBD oil will be sold to wholesalers and medicinal CPG product manufacturers through GMP-certified lab owner, CBD Export Global.

The distribution channel covers the entire EU-zone as well as Switzerland and Lichtenstein, and shipments are expected to commence in 2020 with increasing volumes during duration of the agreement.

CBD exports agreement

The agreement with the Quebec, Canada-based CBD Export Global expands PharmaCielo’s distribution network in Europe with shipments into the EU to commence in 2020 with increased volumes during the duration of the agreement as B2B markets are expanded.

A minimum target volume of 2,000 kg has been agreed to in the first year of the three-year performance-based agreement, allowing for confirmation of individual market regulatory approvals and enabling increased sales volume expansion in subsequent years. …

Distribution by PharmaCielo into European countries under the agreement is subject to the approval of the TSX Venture Exchange.

Read more.